“Treatment Related Adverse Events and Monitoring of Patients Receiving Biologic or Small Molecule Therapy for Inflammatory Bowel Disease” (2024) Canadian IBD Today, 2(2), pp. 19–27. doi:10.58931/cibdt.2024.2230.